CASI Pharmaceuticals sells Alesta stake to BioMarin for US$5.9 millionPUBT·Sep 2 at 11:02 AMBMRN-2.16%
CASI net loss narrows to USD 20 million in H1 FY26; revenue falls 5.8% to USD 9.8 millionPUBT·Aug 14 at 10:45 AMCASIF0.00%
CASI Pharmaceuticals Announces First Half 2026 Business and Financial Results | CASIF Stock NewsStockTitan·Aug 14 at 02:45 AMCASIF0.00%
CASI wins HKIAC arbitration award topping RMB 100 million against JuventasPUBT·Jul 15 at 10:31 AMCASIF0.00%
CASI doses first patient in Phase 1/2 CID-103 trial for renal allograft antibody-mediated rejection in ChinaPUBT·Jul 1 at 12:17 PMCASIF0.00%
CASI Pharmaceuticals settles Evomela China license arbitration with AcrotechPUBT·Jun 29 at 10:30 AMCASIF0.00%
CASI Pharmaceuticals Closes Final US$5 Million Tranche of US$20 Million Convertible NotesTip Ranks·Apr 20 at 01:24 PMCASIF0.00%
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga_article·Feb 25 at 09:07 PMVHT+0.06%BBH-0.54%
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga_article·Feb 25 at 05:05 PMBIB-0.61%CDIOW0.00%
Dow Jumps 200 Points; Lowe's Issues Weak Earnings Outlookbenzinga_article·Feb 25 at 02:55 PMCASI0.00%.DJI+0.49%
